(Q40789599)

23 September 2017

1 reference

title

Monoclonal antibodies and superantigens: a novel therapeutic approach (English)

1 reference

23 September 2017

2

M Dohlsten

1 reference

23 September 2017

6

G Hedlund

1 reference

23 September 2017

T Kalland

1

1 reference

23 September 2017

P Lind

3

1 reference

23 September 2017

A Sundstedt

4

1 reference

23 September 2017

L Abrahmsén

5

1 reference

23 September 2017

P Björk

7

1 reference

23 September 2017

P A Lando

8

1 reference

23 September 2017

M Björklund

9

1 reference

23 September 2017

publication date

1 January 1993

1 reference

Medical oncology and tumor pharmacotherapy

23 September 2017

published in

1 reference

23 September 2017

volume

10

1 reference

23 September 2017

issue

1-2

1 reference

23 September 2017

page(s)

37-47

1 reference

A recombinant C-terminal fragment of staphylococcal enterotoxin A binds to human MHC class II products but does not activate T cells

23 September 2017

cites work

1 reference

12 December 2020

Staphylococcal enterotoxin-dependent cell-mediated cytotoxicity

1 reference

12 December 2020

Programmed cell death and extrathymic reduction of Vβ8+CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B

1 reference

12 December 2020

Production of tumor necrosis factor by human monocytes in response to toxic-shock-syndrome toxin-1

1 reference

12 December 2020

HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells

1 reference

12 December 2020

Binding of staphylococcal enterotoxin A to HLA-DR on B cell lines

1 reference

12 December 2020

Mouse monoclonal antibodies for experimental immunotherapy promotes killing of tumor cells

1 reference

12 December 2020

Antiidiotype antibody therapy of B-cell lymphoma

1 reference

12 December 2020

Evidence for a viral superantigen in humans

1 reference

12 December 2020

Activation of MHC class I-restricted CD8+ CTL by microbial T cell mitogens. Dependence upon MHC class II expression of the target cells and V beta usage of the responder T cells

1 reference

12 December 2020

The TcR-CD3 complex is required for activation of human lymphocytes with staphylococcal enterotoxin A

1 reference

12 December 2020

In vivo T-cell activation by staphylococcal enterotoxin B prevents outgrowth of a malignant tumor

1 reference

12 December 2020

T cell killing of human colon carcinomas by monoclonal-antibody-targeted superantigens

1 reference

12 December 2020

The staphylococcal enterotoxins and their relatives.

1 reference

12 December 2020

Staphylococcal enterotoxins direct and trigger CTL killing of autologous HLA-DR+ mononuclear leukocytes and freshly prepared leukemia cells

1 reference

12 December 2020

An evolutionary conserved mechanism of T cell activation by microbial toxins. Evidence for different affinities of T cell receptor-toxin interaction

1 reference

12 December 2020

Superantigens interact with MHC class II molecules outside of the antigen groove.

1 reference

12 December 2020

Transport of molecules in the tumor interstitium: a review

1 reference

12 December 2020

Isolation, partial characterization, and molecular cloning of a human colon adenocarcinoma cell-surface glycoprotein recognized by the C215 mouse monoclonal antibody

1 reference

12 December 2020

High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR

1 reference

12 December 2020

Human major histocompatibility complex class II-negative colon carcinoma cells present staphylococcal superantigens to cytotoxic T lymphocytes: evidence for a novel enterotoxin receptor

1 reference

12 December 2020

Superantigen-based tumor therapy: in vivo activation of cytotoxic T cells

1 reference

12 December 2020

Relative ability of mitogens to stimulate production of interferon by lymphoid cells and to induce suppression of the in vitro immune response

1 reference

12 December 2020

Effect of enterotoxin B on human volunteers

1 reference

12 December 2020

Localization of an immune functional site on staphylococcal enterotoxin A using the synthetic peptide approach

1 reference

12 December 2020

Mutations defining functional regions of the superantigen staphylococcal enterotoxin B.

1 reference

12 December 2020

Treatment of B cell malignancies with 131I Lym-1 monoclonal antibodies.

1 reference

12 December 2020

Induction of human interleukin-1 by a product of Staphylococcus aureus associated with toxic shock syndrome

1 reference

12 December 2020

Kinetics of IL-2 and interferon-gamma production, expression of IL-2 receptors, and cell proliferation in human mononuclear cells exposed to staphylococcal enterotoxin A

1 reference

12 December 2020

Targeting of human cytotoxic T lymphocytes to MHC class II-expressing cells by staphylococcal enterotoxins

1 reference

12 December 2020

Clinical effects and toxicity of interleukin-2 in patients with cancer

1 reference

12 December 2020

Bacterial superantigens as anti-tumour agents: induction of tumour cytotoxicity in human lymphocytes by staphylococcal enterotoxin A.

1 reference

12 December 2020

A phase II trial of recombinant tumor necrosis factor in patients with advanced colorectal carcinoma

1 reference

12 December 2020

Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents

1 reference

12 December 2020

T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells

1 reference

12 December 2020

Crystal structure of staphylococcal enterotoxin B, a superantigen

1 reference

12 December 2020

Identifiers

1 reference